Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free UTL Stock Alerts

Unitil (UTL) Financials

Unitil logo
$50.79 -0.15 (-0.29%)
As of 02:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Unitil

Annual Income Statements for Unitil

This table shows Unitil's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 26 27 29 33 44 32 36 41 45 47 50
Consolidated Net Income / (Loss)		 26 27 29 93 125 32 36 41 45 47 50
Net Income / (Loss) Continuing Operations		 26 27 29 93 125 32 36 41 45 47 50
Total Pre-Tax Income 		42 43 47 41 58 42 48 53 58 61 66
Total Operating Income		 63 70 75 71 73 71 78 81 87 91 101
Total Gross Profit		 109 117 122 352 348 150 137 169 183 197 221
Total Revenue		 427 383 406 444 438 419 473 563 557 495 536
Operating Revenue		 421 383 406 444 438 419 473 563 557 495 536
Total Cost of Revenue		 318 267 284 92 90 269 336 394 374 298 315
Operating Cost of Revenue		 300 247 263 70 67 269 312 394 374 298 315
Total Operating Expenses		 46 47 47 281 194 78 60 89 96 106 120
Depreciation Expense		 46 47 47 50 52 55 60 63 67 76 89
Other Operating Expenses / (Income)		 - - - 231 142 24 - 26 29 30 31
Total Other Income / (Expense), net		 -21 -28 -29 30 -15 -29 -30 -28 -29 -30 -36
Interest & Investment Income		 -22 -23 -23 -24 -24 -24 -26 -26 -29 -29 -37
Other Income / (Expense), net		 0.50 -5.20 -5.80 -5.80 8.60 -5.20 -4.60 -2.40 0.00 -0.20 1.00
Income Tax Expense		 15 15 18 8.39 14 10 12 11 13 14 15
Basic Earnings per Share		 $1.89 $1.94 $2.06 $2.23 $2.97 $2.15 $2.35 $2.59 $2.82 $2.93 $2.97
Weighted Average Basic Shares Outstanding		 13.90M 14M 14.10M 14.80M 14.90M 14.95M 15.37M 15.99M 16.05M 16.10M 16.79M
Diluted Earnings per Share		 $1.89 $1.94 $2.06 $2.23 $2.97 $2.15 $2.35 $2.59 $2.82 $2.93 $2.97
Weighted Average Diluted Shares Outstanding		 13.90M 14M 14.10M 14.80M 14.90M 14.95M 15.38M 16.00M 16.05M 16.11M 16.79M
Weighted Average Basic & Diluted Shares Outstanding		 13.90M 14M 14.10M 14.80M 14.90M 15M 15.40M 16.08M 16.16M 16.25M 17.98M
Cash Dividends to Common per Share		 $1.40 $1.42 $1.44 $1.46 $1.48 $1.50 $1.52 $1.56 $1.62 $1.70 $1.80

Quarterly Income Statements for Unitil

This table shows Unitil's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.40 16 27 4.30 0.00 16 28 4.00 -0.30 19 33
Consolidated Net Income / (Loss)		 1.40 16 27 4.30 0.00 16 28 4.00 -0.30 19 33
Net Income / (Loss) Continuing Operations		 1.40 16 27 4.30 0.00 16 28 4.00 -0.30 19 33
Total Pre-Tax Income 		1.00 20 37 4.90 -1.30 21 37 4.70 -1.60 25 45
Total Operating Income		 8.00 28 44 12 5.80 28 46 13 7.00 35 56
Total Gross Profit		 32 53 70 38 33 56 76 42 38 66 88
Total Revenue		 104 130 179 96 93 128 171 103 101 162 217
Operating Revenue		 104 130 179 96 93 128 171 103 101 162 217
Total Cost of Revenue		 72 77 109 58 60 71 95 61 63 96 129
Operating Cost of Revenue		 72 77 109 58 60 71 95 61 63 96 129
Total Operating Expenses		 24 25 26 25 27 28 30 28 31 31 32
Depreciation Expense		 17 17 18 18 19 21 22 22 22 23 23
Other Operating Expenses / (Income)		 7.00 7.40 7.70 7.10 7.80 7.30 7.90 6.60 8.60 8.20 9.10
Total Other Income / (Expense), net		 -7.00 -7.70 -7.60 -7.50 -7.10 -7.30 -9.20 -8.60 -8.60 -9.30 -11
Interest & Investment Income		 -7.00 -7.60 -7.30 -7.40 -7.40 -7.20 -9.10 -9.30 -8.90 -9.40 -11
Other Income / (Expense), net		 0.00 -0.10 -0.30 -0.10 0.30 -0.10 -0.10 0.70 0.30 0.10 0.00
Income Tax Expense		 -0.40 4.60 9.40 0.60 -1.30 5.30 9.50 0.70 -1.30 6.40 12
Basic Earnings per Share		 $0.09 $0.97 $1.69 $0.27 $0.00 $0.97 $1.69 $0.25 ($0.02) $1.05 $1.85
Weighted Average Basic Shares Outstanding		 16.10M 16.05M 16.10M 16.10M 16.10M 16.10M 16.15M 16.17M 16.98M 16.79M 17.87M
Diluted Earnings per Share		 $0.09 $0.97 $1.69 $0.27 $0.00 $0.97 $1.69 $0.25 ($0.02) $1.05 $1.85
Weighted Average Diluted Shares Outstanding		 16.10M 16.05M 16.10M 16.10M 16.10M 16.11M 16.16M 16.18M 16.98M 16.79M 17.88M
Weighted Average Basic & Diluted Shares Outstanding		 16.10M 16.16M 16.17M 16.17M 16.19M 16.25M 16.25M 16.29M 17.91M 17.98M 17.99M
Cash Dividends to Common per Share		 $0.41 - $0.43 - $0.43 - $0.45 - $0.45 - $0.48

Annual Cash Flow Statements for Unitil

This table details how cash moves in and out of Unitil's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.30 -2.90 3.10 -1.10 -2.60 0.80 0.50 2.50 -2.50 -0.20 9.30
Net Cash From Operating Activities		 115 68 86 79 105 76 108 98 107 126 131
Net Cash From Continuing Operating Activities		 115 68 28 79 105 76 108 98 107 126 131
Net Income / (Loss) Continuing Operations		 26 27 -29 33 44 32 36 41 45 47 50
Consolidated Net Income / (Loss)		 26 27 29 33 44 32 36 41 45 47 50
Depreciation Expense		 46 47 47 50 52 55 60 63 67 76 89
Non-Cash Adjustments To Reconcile Net Income		 - -11 -3.80 -1.40 -8.70 -0.90 -10 -12 9.40 -14 -0.30
Changes in Operating Assets and Liabilities, net		 43 5.70 14 -3.50 17 -10 23 5.30 -15 17 -7.30
Net Cash From Investing Activities		 -104 -98 -119 -102 -106 -123 -115 -122 -141 -170 -346
Net Cash From Continuing Investing Activities		 -104 -98 -119 -102 -106 -123 -115 -122 -141 -170 -346
Purchase of Property, Plant & Equipment		 -104 -98 -119 -102 -119 -123 -115 -122 -141 -170 -185
Acquisitions		 - - - - - - - - 0.00 0.00 -160
Net Cash From Financing Activities		 -11 27 36 23 -1.70 48 7.70 27 32 44 224
Net Cash From Continuing Financing Activities		 -11 27 36 23 -1.70 48 7.70 27 32 44 224
Repayment of Debt		 -7.40 -22 -63 -30 -43 -25 -26 -10 -7.10 -6.00 -5.10
Payment of Dividends		 -20 -20 -20 -22 -22 -23 -24 -25 -26 -28 -30
Issuance of Debt		 19 70 89 75 70 96 9.40 52 71 79 182
Issuance of Common Equity		 1.30 1.30 33 1.20 1.10 1.10 46 1.00 1.10 1.10 74
Other Financing Activities, net		 -4.00 -2.50 -2.40 -0.90 -7.30 -1.20 2.20 9.50 -7.30 -2.60 3.50
Cash Interest Paid		 22 22 23 25 24 24 26 26 31 31 39
Cash Income Taxes Paid		 1.80 1.60 0.00 0.40 0.80 0.90 1.40 1.20 0.00 2.50 4.90

Quarterly Cash Flow Statements for Unitil

This table details how cash moves in and out of Unitil's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.80 0.50 -0.20 -3.50 3.50 - 3.90 -1.70 6.10 1.00 1.30
Net Cash From Operating Activities		 16 28 27 50 26 23 52 42 16 21 50
Net Cash From Continuing Operating Activities		 16 28 27 50 26 23 52 42 16 21 50
Net Income / (Loss) Continuing Operations		 1.40 16 27 4.30 - 16 28 4.00 -0.30 19 33
Consolidated Net Income / (Loss)		 1.40 16 27 4.30 - 16 28 4.00 -0.30 19 33
Depreciation Expense		 17 17 18 18 19 21 22 22 22 23 23
Non-Cash Adjustments To Reconcile Net Income		 3.10 -6.10 -8.80 6.30 0.50 -12 23 2.40 -7.90 -18 8.80
Changes in Operating Assets and Liabilities, net		 -5.00 1.60 -9.80 21 6.50 -1.20 -20 14 1.60 -2.90 -15
Net Cash From Investing Activities		 -36 -48 -20 -37 -57 -56 -104 -40 -55 -147 -32
Net Cash From Continuing Investing Activities		 -36 -48 -20 -37 -57 -56 -104 -40 -55 -147 -32
Purchase of Property, Plant & Equipment		 -36 -48 -20 -37 -57 -56 -33 -40 -55 -58 -32
Acquisitions		 - - 0.00 - - - -71 -0.20 - -89 0.00
Net Cash From Financing Activities		 19 20 -6.60 -17 35 32 56 -3.50 45 126 -16
Net Cash From Continuing Financing Activities		 19 20 -6.60 -17 35 32 56 -3.50 45 127 -16
Repayment of Debt		 11 -16 -1.30 -1.50 -101 98 -1.30 -1.50 -2.30 - -1.30
Payment of Dividends		 -6.50 -6.60 -6.80 -6.90 -6.90 -6.90 -7.30 -7.30 -7.40 -8.10 -8.50
Issuance of Debt		 9.30 46 7.90 -12 139 -56 67 -1.50 -22 138 2.30
Issuance of Common Equity		 0.20 0.30 0.30 0.30 0.10 0.40 0.30 1.70 71 0.10 0.30
Other Financing Activities, net		 4.50 -4.40 -6.70 3.50 3.20 -2.60 -3.20 5.10 5.30 -3.70 -9.20
Cash Interest Paid		 6.50 8.90 7.00 9.70 6.90 7.60 10 9.40 10 9.10 13
Cash Income Taxes Paid		 - - 0.00 2.50 - - 0.00 3.00 1.90 - 0.00

Annual Balance Sheets for Unitil

This table presents Unitil's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,039 1,128 1,242 1,298 1,371 1,478 1,540 1,590 1,670 1,795 2,134
Total Current Assets		 121 132 151 152 131 139 160 195 177 189 240
Cash & Equivalents		 8.70 5.80 8.90 7.80 5.20 6.00 6.50 9.00 6.50 6.30 16
Accounts Receivable		 99 111 127 130 111 118 136 165 148 159 195
Inventories, net		 0.80 7.40 7.50 7.80 8.70 9.10 9.60 13 15 15 17
Prepaid Expenses		 12 7.70 8.40 7.00 5.80 6.40 8.10 8.00 8.30 8.40 12
Current Deferred & Refundable Income Taxes		 - - - - - - - - - - 0.00
Plant, Property, & Equipment, net		 809 883 972 1,037 1,112 1,193 1,257 1,332 1,421 1,540 1,799
Plant, Property & Equipment, gross		 2,126 2,311 1,279 2,656 1,468 1,595 1,689 1,791 1,908 2,051 2,342
Accumulated Depreciation		 272 290 308 333 356 402 432 460 487 512 544
Total Noncurrent Assets		 109 113 119 109 128 1,339 123 64 72 66 96
Goodwill		 - - - - - - - - - 0.00 4.30
Other Noncurrent Operating Assets		 109 113 119 109 128 1,339 123 64 72 66 91
Total Liabilities & Shareholders' Equity		 1,039 1,128 1,242 1,298 1,371 1,478 1,540 1,590 1,670 1,795 2,134
Total Liabilities		 756 835 905 947 994 1,089 1,092 1,123 1,181 1,282 1,525
Total Current Liabilities		 144 177 151 193 160 136 174 260 277 229 426
Short-Term Debt		 62 102 71 101 78 63 72 123 167 111 294
Accounts Payable		 33 32 42 43 38 33 52 69 48 50 63
Accrued Expenses		 1.30 0.40 0.50 0.60 0.60 0.30 0.50 0.60 0.60 0.70 0.80
Current Deferred & Payable Income Tax Liabilities		 - - - - - - - 0.40 1.90 0.00 0.60
Other Current Liabilities		 48 42 38 48 44 39 48 68 54 59 59
Other Current Nonoperating Liabilities		 - - - - - - - - 6.00 8.40 9.40
Total Noncurrent Liabilities		 612 658 754 755 834 953 918 863 904 1,053 1,099
Long-Term Debt		 306 317 376 387 438 523 498 489 509 638 633
Capital Lease Obligations		 11 8.30 5.70 - - - - 2.80 3.70 4.90 4.90
Asset Retirement Reserve & Litigation Obligation		 80 81 135 139 145 151 152 157 165 193 224
Noncurrent Deferred & Payable Income Tax Liabilities		 88 98 83 98 104 109 128 163 176 186 197
Noncurrent Employee Benefit Liabilities		 124 149 150 122 142 162 134 47 46 26 33
Other Noncurrent Operating Liabilities		 3.60 5.10 4.30 8.70 6.50 6.90 6.60 3.80 4.60 5.30 7.30
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 283 293 337 351 377 389 449 468 489 513 610
Total Preferred & Common Equity		 283 293 337 351 377 389 449 468 489 513 610
Preferred Stock		 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Total Common Equity		 283 293 337 351 377 389 448 467 489 512 609
Common Stock		 238 241 276 279 283 285 332 335 338 341 418
Retained Earnings		 45 52 61 72 94 104 116 133 152 171 191

Quarterly Balance Sheets for Unitil

This table presents Unitil's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 1,579 1,615 1,595 1,620 1,698 1,695 1,737 1,891 1,893 1,945 2,156
Total Current Assets		 151 198 161 156 189 160 163 196 170 184 237
Cash & Equivalents		 7.90 6.80 6.80 6.00 6.30 2.80 6.30 10 8.50 15 17
Accounts Receivable		 124 169 129 129 158 132 131 158 132 143 187
Inventories, net		 12 13 14 14 14 15 15 17 17 16 17
Prepaid Expenses		 7.20 9.40 11 7.60 11 11 6.90 11 13 9.40 17
Current Deferred & Refundable Income Taxes		 - - - 0.00 - - 3.80 0.00 - 0.00 0.00
Plant, Property, & Equipment, net		 1,304 1,341 1,358 1,390 1,430 1,455 1,502 1,619 1,644 1,683 1,813
Plant, Property & Equipment, gross		 1,757 1,808 1,832 1,874 1,923 1,955 2,015 2,141 2,175 2,225 2,367
Accumulated Depreciation		 453 466 475 484 493 500 512 522 531 542 554
Total Noncurrent Assets		 125 76 76 74 79 80 72 76 78 78 106
Goodwill		 - - - - - 0.00 0.00 0.00 1.60 1.60 4.30
Other Noncurrent Operating Assets		 125 76 76 74 79 80 72 76 77 77 102
Total Liabilities & Shareholders' Equity		 1,579 1,615 1,595 1,620 1,698 1,695 1,737 1,891 1,893 1,945 2,156
Total Liabilities		 1,120 1,128 1,111 1,140 1,187 1,186 1,235 1,357 1,360 1,348 1,520
Total Current Liabilities		 194 254 238 243 277 274 179 295 294 275 416
Short-Term Debt		 80 147 139 137 175 163 69 178 176 152 296
Accounts Payable		 35 46 37 36 38 37 36 43 41 43 47
Accrued Expenses		 0.60 0.60 0.60 0.60 0.70 0.70 0.80 0.70 0.70 0.80 0.80
Current Deferred & Payable Income Tax Liabilities		 0.00 1.20 2.30 0.70 8.90 8.00 0.00 10 6.00 3.20 11
Other Current Liabilities		 71 52 55 64 47 60 66 55 61 68 53
Other Current Nonoperating Liabilities		 6.50 6.10 5.20 6.50 7.20 6.00 7.40 7.90 8.60 7.90 8.20
Total Noncurrent Liabilities		 927 875 873 897 911 912 1,056 1,062 1,066 1,073 1,104
Long-Term Debt		 493 488 486 509 508 506 638 637 636 636 631
Capital Lease Obligations		 - - - - 3.80 3.40 3.00 4.40 4.00 4.90 4.50
Asset Retirement Reserve & Litigation Obligation		 156 160 163 165 169 172 190 204 207 212 229
Noncurrent Deferred & Payable Income Tax Liabilities		 136 171 171 174 179 179 177 185 187 188 198
Noncurrent Employee Benefit Liabilities		 135 47 44 41 46 46 43 26 26 26 33
Other Noncurrent Operating Liabilities		 6.60 8.60 8.30 8.40 5.00 4.90 5.40 5.90 6.10 6.60 7.50
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 459 486 484 480 511 509 502 534 533 597 636
Total Preferred & Common Equity		 459 486 484 480 511 509 502 534 533 597 636
Preferred Stock		 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Total Common Equity		 459 486 484 480 511 509 502 534 533 597 636
Common Stock		 334 336 337 337 339 339 340 343 345 417 420
Retained Earnings		 124 150 148 143 172 169 162 191 188 180 216

Annual Metrics And Ratios for Unitil

This table displays calculated financial ratios and metrics derived from Unitil's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.23% -10.17% 5.95% 9.33% -1.33% -4.47% 13.07% 18.99% -1.08% -11.18% 8.33%
EBITDA Growth		 7.47% 2.10% 4.39% -0.60% 15.46% -9.72% 9.94% 6.03% 9.81% 7.77% 14.65%
EBIT Growth		 6.71% 2.20% 7.08% -6.03% 24.92% -18.97% 10.57% 6.69% 11.52% 3.79% 13.05%
NOPAT Growth		 3.73% 12.85% 4.87% 20.72% -1.86% -2.66% 8.82% 7.38% 6.40% 3.60% 11.05%
Net Income Growth		 6.48% 3.22% 6.83% 219.33% 35.41% -74.32% 12.11% 14.68% 9.18% 4.20% 6.58%
EPS Growth		 5.59% 2.65% 6.19% 8.25% 33.18% -27.61% 9.30% 10.21% 8.88% 3.90% 1.37%
Operating Cash Flow Growth		 37.02% -40.66% 26.21% -8.93% 33.63% -27.84% 42.40% -9.37% 9.52% 17.66% 4.29%
Free Cash Flow Firm Growth		 125.07% -174.61% -21.35% 128.86% -89.47% -201,218.77% 199.04% -99.81% -1,334.31% -8.51% -522.41%
Invested Capital Growth		 2.78% 9.39% 9.38% 6.53% 6.62% 143.77% -53.20% 6.04% 8.88% 8.57% 20.96%
Revenue Q/Q Growth		 -3.92% 0.50% 2.81% 2.35% -2.06% 0.12% 5.08% 4.01% -5.42% -0.42% 6.77%
EBITDA Q/Q Growth		 -0.36% 2.20% 2.28% -1.53% 0.22% 3.52% 1.76% 0.43% 2.79% 2.46% 4.83%
EBIT Q/Q Growth		 -1.70% 4.00% 3.57% -4.53% 0.37% 5.25% 1.53% -0.13% 3.08% 0.44% 7.02%
NOPAT Q/Q Growth		 -3.02% 14.37% -2.14% 2.09% -0.42% 4.57% 1.62% -0.23% 2.40% -0.66% 6.75%
Net Income Q/Q Growth		 -0.38% 3.61% 3.40% 178.94% 21.27% -71.04% 2.56% 0.00% 2.26% 0.21% 7.27%
EPS Q/Q Growth		 -1.05% 3.19% 3.00% -2.19% 1.02% 6.44% 0.43% 0.00% 2.17% 0.00% 2.77%
Operating Cash Flow Q/Q Growth		 2.77% 1.64% 7.35% -3.68% 4.17% -13.58% 11.48% 3.28% 14.19% -3.82% -1.43%
Free Cash Flow Firm Q/Q Growth		 10.48% 44.19% -381.56% 158.28% -95.74% -3,820.98% 10,835.68% -81.49% 4.71% -101.80% -94.88%
Invested Capital Q/Q Growth		 5.07% 3.49% 5.24% 3.02% 4.45% 131.95% 3.34% 4.12% 3.79% 4.75% 10.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 25.49% 30.46% 30.11% 79.31% 79.48% 35.79% 29.01% 30.01% 32.85% 39.73% 41.27%
EBITDA Margin		 25.61% 29.11% 28.68% 26.08% 30.51% 28.83% 28.04% 24.98% 27.73% 33.65% 35.62%
Operating Margin		 14.78% 18.31% 18.56% 16.03% 16.68% 17.06% 16.44% 14.29% 15.63% 18.31% 18.88%
EBIT Margin		 14.90% 16.95% 17.13% 14.73% 18.64% 15.81% 15.47% 13.87% 15.63% 18.27% 19.07%
Profit (Net Income) Margin		 6.16% 7.08% 7.14% 20.85% 28.62% 7.69% 7.63% 7.35% 8.11% 9.52% 9.37%
Tax Burden Percent		 63.07% 63.87% 62.37% 223.69% 216.21% 75.94% 75.84% 78.71% 77.40% 77.09% 76.64%
Interest Burden Percent		 65.57% 65.38% 66.81% 63.30% 70.99% 64.05% 65.03% 67.35% 67.05% 67.59% 64.09%
Effective Tax Rate		 37.03% 36.13% 37.63% 20.27% 23.79% 24.06% 24.16% 21.29% 22.60% 22.91% 23.36%
Return on Invested Capital (ROIC)		 6.17% 6.56% 6.29% 7.04% 6.48% 3.56% 3.72% 6.08% 6.01% 5.73% 5.53%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.50% 2.09% 2.12% 14.79% 20.54% 1.63% 1.76% 2.32% 2.56% 2.56% 2.28%
Return on Net Nonoperating Assets (RNNOA)		 3.29% 2.87% 2.92% 19.88% 27.97% 4.85% 4.90% 2.96% 3.43% 3.67% 3.41%
Return on Equity (ROE)		 9.46% 9.43% 9.21% 26.92% 34.45% 8.41% 8.62% 9.04% 9.45% 9.40% 8.95%
Cash Return on Invested Capital (CROIC)		 3.43% -2.41% -2.67% 0.71% 0.07% -80.09% 76.20% 0.22% -2.49% -2.48% -13.44%
Operating Return on Assets (OROA)		 6.24% 6.00% 5.87% 5.15% 6.12% 4.65% 4.85% 4.99% 5.34% 5.22% 5.20%
Return on Assets (ROA)		 2.58% 2.51% 2.45% 7.29% 9.40% 2.26% 2.39% 2.64% 2.77% 2.72% 2.56%
Return on Common Equity (ROCE)		 9.45% 9.42% 9.20% 26.90% 34.43% 8.40% 8.61% 9.03% 9.44% 9.40% 8.94%
Return on Equity Simple (ROE_SIMPLE)		 9.30% 9.26% 8.61% 26.36% 33.28% 8.27% 8.05% 8.85% 9.24% 9.19% 0.00%
Net Operating Profit after Tax (NOPAT)		 40 45 47 57 56 54 59 63 67 70 78
NOPAT Margin		 9.31% 11.70% 11.58% 12.78% 12.71% 12.95% 12.47% 11.25% 12.10% 14.11% 14.47%
Net Nonoperating Expense Percent (NNEP)		 3.67% 4.47% 4.17% -7.75% -14.06% 1.93% 1.96% 3.76% 3.46% 3.17% 3.26%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 5.85% 5.77% 5.51% 5.03%
Cost of Revenue to Revenue		 74.51% 69.54% 69.89% 20.69% 20.52% 64.21% 70.99% 69.99% 67.15% 60.27% 58.73%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 10.71% 12.15% 11.55% 63.27% 44.27% 18.73% 12.57% 15.71% 17.21% 21.42% 22.39%
Earnings before Interest and Taxes (EBIT)		 64 65 70 65 82 66 73 78 87 90 102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 109 112 117 116 134 121 133 141 155 167 191
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.34 1.70 1.54 1.78 2.09 1.51 1.49 1.66 1.68 1.71 1.42
Price to Tangible Book Value (P/TBV)		 1.34 1.70 1.54 1.78 2.09 1.51 1.49 1.66 1.68 1.71 1.43
Price to Revenue (P/Rev)		 0.89 1.30 1.28 1.41 1.80 1.40 1.42 1.37 1.47 1.77 1.62
Price to Earnings (P/E)		 14.42 18.41 17.91 18.98 17.82 18.21 18.55 18.69 18.15 18.63 17.29
Dividend Yield		 5.16% 4.00% 3.91% 3.47% 2.80% 3.84% 3.62% 4.04% 3.18% 3.14% 3.72%
Earnings Yield		 6.94% 5.43% 5.58% 5.27% 5.61% 5.49% 5.39% 5.35% 5.51% 5.37% 5.78%
Enterprise Value to Invested Capital (EV/IC)		 1.15 1.29 1.23 1.33 1.46 0.54 1.22 1.29 1.28 1.28 1.16
Enterprise Value to Revenue (EV/Rev)		 1.76 2.40 2.37 2.49 2.96 2.79 2.61 2.45 2.68 3.28 3.33
Enterprise Value to EBITDA (EV/EBITDA)		 6.86 8.24 8.27 9.56 9.71 9.67 9.30 9.81 9.67 9.76 9.34
Enterprise Value to EBIT (EV/EBIT)		 11.78 14.15 13.85 16.93 15.89 17.63 16.85 17.67 17.15 17.98 17.45
Enterprise Value to NOPAT (EV/NOPAT)		 18.86 20.52 20.50 19.51 23.30 21.52 20.91 21.78 22.16 23.27 22.99
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.51 13.47 11.18 14.11 12.38 15.42 11.44 14.12 13.96 12.91 13.58
Enterprise Value to Free Cash Flow (EV/FCFF)		 33.97 0.00 0.00 192.05 2,137.83 0.00 1.02 610.68 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.34 1.46 1.35 1.39 1.37 1.51 1.27 1.31 1.39 1.47 1.53
Long-Term Debt to Equity		 1.12 1.11 1.13 1.10 1.16 1.34 1.11 1.05 1.05 1.26 1.05
Financial Leverage		 1.32 1.37 1.37 1.34 1.36 2.98 2.79 1.28 1.34 1.43 1.50
Leverage Ratio		 3.67 3.76 3.76 3.69 3.67 3.72 3.60 3.42 3.41 3.46 3.50
Compound Leverage Factor		 2.40 2.46 2.51 2.34 2.60 2.38 2.34 2.30 2.28 2.34 2.24
Debt to Total Capital		 57.25% 59.29% 57.37% 58.17% 57.78% 60.10% 55.97% 56.79% 58.14% 59.53% 60.43%
Short-Term Debt to Total Capital		 9.40% 14.13% 9.01% 12.05% 8.75% 6.48% 7.10% 11.34% 14.28% 8.74% 19.06%
Long-Term Debt to Total Capital		 47.85% 45.16% 48.35% 46.12% 49.03% 53.62% 48.87% 45.45% 43.87% 50.79% 41.38%
Preferred Equity to Total Capital		 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 42.72% 40.69% 42.61% 41.80% 42.20% 39.88% 44.01% 43.19% 41.84% 40.45% 39.55%
Debt to EBITDA		 3.46 3.82 3.89 4.22 3.86 4.86 4.30 4.37 4.40 4.53 4.88
Net Debt to EBITDA		 3.39 3.77 3.81 4.15 3.82 4.81 4.25 4.30 4.36 4.49 4.80
Long-Term Debt to EBITDA		 2.90 2.91 3.28 3.35 3.27 4.33 3.75 3.50 3.32 3.86 3.34
Debt to NOPAT		 9.53 9.52 9.64 8.61 9.26 10.81 9.66 9.70 10.08 10.80 12.00
Net Debt to NOPAT		 9.31 9.39 9.45 8.47 9.16 10.70 9.55 9.56 9.99 10.71 11.80
Long-Term Debt to NOPAT		 7.97 7.25 8.12 6.82 7.85 9.65 8.44 7.76 7.61 9.21 8.22
Altman Z-Score		 0.95 0.90 0.93 0.95 1.06 0.86 0.93 1.00 0.98 0.96 0.77
Noncontrolling Interest Sharing Ratio		 0.07% 0.07% 0.06% 0.06% 0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.84 0.74 1.00 0.79 0.82 1.02 0.92 0.75 0.64 0.83 0.56
Quick Ratio		 0.75 0.66 0.90 0.71 0.73 0.91 0.82 0.67 0.56 0.72 0.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 -16 -20 5.77 0.61 -1,221 1,210 2.26 -28 -30 -188
Operating Cash Flow to CapEx		 110.78% 69.62% 72.25% 76.66% 88.00% 61.75% 93.74% 80.02% 75.89% 74.10% 70.93%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.42 0.35 0.34 0.35 0.33 0.29 0.31 0.36 0.34 0.29 0.27
Accounts Receivable Turnover		 3.82 3.65 3.43 3.47 3.64 3.66 3.74 3.75 3.57 3.23 3.03
Inventory Turnover		 334.74 65.02 38.11 12.01 10.90 30.20 35.94 34.58 27.01 20.01 19.68
Fixed Asset Turnover		 0.55 0.45 0.44 0.44 0.41 0.36 0.39 0.44 0.40 0.33 0.32
Accounts Payable Turnover		 8.21 8.12 7.68 2.19 2.24 7.59 7.85 6.52 6.43 6.12 5.59
Days Sales Outstanding (DSO)		 95.57 99.96 106.57 105.24 100.29 99.84 97.67 97.24 102.34 113.09 120.60
Days Inventory Outstanding (DIO)		 1.09 5.61 9.58 30.38 33.50 12.09 10.16 10.56 13.51 18.24 18.55
Days Payable Outstanding (DPO)		 44.48 44.97 47.51 167.01 162.81 48.07 46.49 56.02 56.74 59.61 65.28
Cash Conversion Cycle (CCC)		 52.18 60.60 68.64 -31.38 -29.03 63.85 61.33 51.78 59.12 71.71 73.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 653 714 781 832 887 2,163 1,012 1,073 1,169 1,269 1,535
Invested Capital Turnover		 0.66 0.56 0.54 0.55 0.51 0.27 0.30 0.54 0.50 0.41 0.38
Increase / (Decrease) in Invested Capital		 18 61 67 51 55 1,276 -1,151 61 95 100 266
Enterprise Value (EV)		 749 920 964 1,107 1,298 1,167 1,234 1,380 1,494 1,625 1,783
Market Capitalization		 379 499 519 626 788 586 670 774 820 877 868
Book Value per Share		 $20.21 $20.83 $23.84 $23.61 $25.23 $25.92 $28.07 $29.14 $30.38 $31.64 $34.02
Tangible Book Value per Share		 $20.21 $20.83 $23.84 $23.61 $25.23 $25.92 $28.07 $29.14 $30.38 $31.64 $33.78
Total Capital		 662 720 790 840 892 976 1,019 1,082 1,169 1,267 1,541
Total Debt		 379 427 453 489 516 586 570 615 680 754 931
Total Long-Term Debt		 317 325 382 387 438 523 498 492 513 643 638
Net Debt		 370 421 444 481 510 580 564 606 673 748 916
Capital Expenditures (CapEx)		 104 98 119 102 119 123 115 122 141 170 185
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 30 51 63 53 44 60 52 48 60 65 92
Debt-free Net Working Capital (DFNWC)		 38 56 72 61 49 66 59 57 67 71 108
Net Working Capital (NWC)		 -24 -45 0.30 -40 -29 3.20 -14 -65 -100 -40 -186
Net Nonoperating Expense (NNE)		 13 18 18 -36 -70 22 23 22 22 23 27
Net Nonoperating Obligations (NNO)		 370 421 444 481 510 1,774 564 606 679 756 925
Total Depreciation and Amortization (D&A)		 46 47 47 50 52 55 60 63 67 76 89
Debt-free, Cash-free Net Working Capital to Revenue		 6.96% 13.20% 15.41% 11.96% 10.04% 14.43% 10.99% 8.59% 10.81% 13.04% 17.22%
Debt-free Net Working Capital to Revenue		 9.00% 14.71% 17.60% 13.71% 11.23% 15.86% 12.36% 10.19% 11.97% 14.31% 20.13%
Net Working Capital to Revenue		 -5.58% -11.82% 0.07% -9.07% -6.60% 0.76% -2.92% -11.59% -17.99% -8.06% -34.65%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.89 $1.94 $2.06 $2.23 $2.97 $2.15 $2.35 $2.59 $2.82 $2.93 $2.97
Adjusted Weighted Average Basic Shares Outstanding		 13.99M 14.07M 14.82M 14.88M 14.93M 15.01M 15.98M 15.99M 16.05M 16.10M 16.79M
Adjusted Diluted Earnings per Share		 $1.89 $1.94 $2.06 $2.23 $2.97 $2.15 $2.35 $2.59 $2.82 $2.93 $2.97
Adjusted Weighted Average Diluted Shares Outstanding		 13.99M 14.07M 14.82M 14.88M 14.93M 15.01M 15.98M 16.00M 16.05M 16.11M 16.79M
Adjusted Basic & Diluted Earnings per Share		 $1.89 $1.94 $2.06 $2.23 $2.97 $2.15 $2.35 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.90M 14M 14.10M 14.80M 14.90M 15M 15.40M 16.08M 16.16M 16.25M 17.98M
Normalized Net Operating Profit after Tax (NOPAT)		 40 45 47 57 56 54 59 63 67 70 78
Normalized NOPAT Margin		 9.31% 11.70% 11.58% 12.78% 12.71% 12.95% 12.47% 11.25% 12.10% 14.11% 14.47%
Pre Tax Income Margin		 9.77% 11.09% 11.45% 9.32% 13.24% 10.13% 10.06% 9.34% 10.48% 12.35% 12.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 74.52% 73.68% 70.34% 23.54% 17.62% 70.19% 65.37% 60.63% 57.96% 58.39% 59.96%
Augmented Payout Ratio		 74.52% 73.68% 70.34% 23.54% 17.62% 70.19% 65.37% 60.63% 57.96% 58.39% 59.96%

Quarterly Metrics And Ratios for Unitil

This table displays calculated financial ratios and metrics derived from Unitil's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 17,983,994.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 17,983,994.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.85
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.72% -19.75% -18.85% -7.45% -10.59% -1.62% -4.42% 7.21% 8.83% 26.67% 26.99%
EBITDA Growth		 6.90% 10.29% 10.14% 6.67% 1.61% 8.89% 9.53% 17.76% 17.06% 17.96% 16.81%
EBIT Growth		 21.21% 10.36% 11.14% 3.36% -23.75% 1.44% 5.01% 13.82% 19.67% 23.84% 21.26%
NOPAT Growth		 122.22% 8.00% 11.80% 7.59% -63.75% -1.81% 4.54% 4.02% 20.69% 23.32% 19.84%
Net Income Growth		 180.00% 6.90% 12.86% 2.38% -100.00% 0.65% 1.10% -6.98% 0.00% 21.79% 20.73%
EPS Growth		 200.00% 6.59% 11.92% 8.00% -100.00% 0.00% 0.00% -7.41% 0.00% 8.25% 9.47%
Operating Cash Flow Growth		 39.32% 88.67% 73.86% 5.94% 60.12% -17.67% 95.86% -15.43% -40.23% -8.15% -3.84%
Free Cash Flow Firm Growth		 -81.37% -79.06% 28.43% 25.44% 3.17% -7.03% -165.16% -132.03% -95.16% -203.53% -40.52%
Invested Capital Growth		 9.23% 8.88% 6.59% 6.64% 7.58% 8.57% 12.77% 13.89% 13.94% 20.96% 15.39%
Revenue Q/Q Growth		 0.48% 24.74% 37.89% -46.45% -2.93% 37.24% 33.96% -39.93% -1.46% 59.74% 34.30%
EBITDA Q/Q Growth		 -12.98% 81.45% 37.56% -50.89% -17.11% 94.44% 38.37% -47.20% -17.60% 95.93% 37.02%
EBIT Q/Q Growth		 -32.77% 246.25% 58.48% -71.98% -50.41% 360.66% 64.06% -69.63% -47.86% 376.71% 60.63%
NOPAT Q/Q Growth		 10.73% 91.41% 53.23% -66.87% -62.69% 418.44% 63.13% -67.04% -56.71% 429.73% 58.53%
Net Income Q/Q Growth		 -66.67% 1,007.14% 75.48% -84.19% -100.00% 0.00% 76.28% -85.45% -107.50% 6,433.33% 74.74%
EPS Q/Q Growth		 -64.00% 977.78% 74.23% -84.02% -100.00% 0.00% 74.23% -85.21% -108.00% 5,350.00% 76.19%
Operating Cash Flow Q/Q Growth		 -65.39% 73.62% -6.01% 87.59% -47.70% -10.73% 123.61% -19.00% -63.03% 37.18% 134.11%
Free Cash Flow Firm Q/Q Growth		 0.10% 11.96% 41.63% -52.91% -29.74% 2.69% -50.11% -29.09% -7.32% -45.95% 30.50%
Invested Capital Q/Q Growth		 1.64% 3.79% 2.54% -1.11% 2.54% 4.75% 6.51% -0.16% 2.55% 10.92% 1.60%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 30.61% 40.51% 39.12% 39.29% 35.20% 44.24% 44.38% 40.64% 37.39% 40.81% 40.71%
EBITDA Margin		 23.87% 34.72% 34.64% 31.77% 27.13% 38.43% 39.70% 34.89% 29.18% 35.79% 36.51%
Operating Margin		 7.70% 21.45% 24.73% 12.96% 6.24% 22.12% 27.05% 12.96% 6.92% 21.49% 25.77%
EBIT Margin		 7.70% 21.37% 24.57% 12.85% 6.57% 22.04% 26.99% 13.65% 7.22% 21.55% 25.77%
Profit (Net Income) Margin		 1.35% 11.96% 15.22% 4.49% 0.00% 12.24% 16.10% 3.90% -0.30% 11.76% 15.31%
Tax Burden Percent		 140.00% 77.11% 74.32% 87.76% 0.00% 74.64% 74.32% 85.11% 18.75% 74.80% 73.61%
Interest Burden Percent		 12.50% 72.56% 83.37% 39.84% -21.31% 74.38% 80.26% 33.57% -21.92% 72.99% 80.68%
Effective Tax Rate		 -40.00% 22.89% 25.68% 12.24% 0.00% 25.36% 25.68% 14.89% 0.00% 25.20% 26.39%
Return on Invested Capital (ROIC)		 5.89% 8.22% 8.19% 5.05% 1.86% 6.70% 7.68% 4.30% 1.87% 6.15% 7.59%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.28% 7.30% 7.33% 4.03% 1.26% 5.94% 6.77% 3.32% 1.18% 5.32% 6.68%
Return on Net Nonoperating Assets (RNNOA)		 5.55% 9.80% 9.69% 5.26% 1.74% 8.52% 9.75% 4.75% 1.61% 7.97% 9.93%
Return on Equity (ROE)		 11.44% 18.02% 17.88% 10.30% 3.60% 15.22% 17.43% 9.06% 3.48% 14.11% 17.52%
Cash Return on Invested Capital (CROIC)		 -2.71% -2.49% -0.26% -0.18% -1.28% -2.48% -6.40% -7.31% -7.44% -13.44% -8.50%
Operating Return on Assets (OROA)		 2.84% 7.30% 7.65% 3.97% 1.94% 6.29% 7.32% 3.76% 1.97% 5.88% 7.41%
Return on Assets (ROA)		 0.50% 4.09% 4.74% 1.39% 0.00% 3.49% 4.37% 1.07% -0.08% 3.21% 4.40%
Return on Common Equity (ROCE)		 11.44% 18.01% 17.87% 10.30% 3.59% 15.21% 17.42% 9.05% 3.48% 14.11% 17.51%
Return on Equity Simple (ROE_SIMPLE)		 9.21% 0.00% 9.46% 9.51% 9.36% 0.00% 8.87% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 11 21 33 11 4.06 21 34 11 4.90 26 41
NOPAT Margin		 10.78% 16.54% 18.38% 11.37% 4.37% 16.51% 20.10% 11.03% 4.85% 16.07% 18.97%
Net Nonoperating Expense Percent (NNEP)		 1.61% 0.92% 0.86% 1.02% 0.60% 0.76% 0.91% 0.98% 0.69% 0.83% 0.91%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.83% - - - 1.66% 2.54% 0.84% 0.35% 1.68% 2.62%
Cost of Revenue to Revenue		 69.39% 59.49% 60.88% 60.71% 64.80% 55.76% 55.62% 59.36% 62.61% 59.20% 59.29%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 22.91% 19.06% 14.38% 26.33% 28.96% 22.12% 17.33% 27.68% 30.46% 19.32% 14.94%
Earnings before Interest and Taxes (EBIT)		 8.00 28 44 12 6.10 28 46 14 7.30 35 56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 25 45 62 30 25 49 68 36 30 58 79
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.39 1.68 1.63 1.63 1.95 1.71 1.76 1.59 1.31 1.42 1.48
Price to Tangible Book Value (P/TBV)		 1.39 1.68 1.63 1.63 1.95 1.71 1.76 1.60 1.31 1.43 1.49
Price to Revenue (P/Rev)		 1.13 1.47 1.61 1.64 1.97 1.77 1.92 1.72 1.55 1.62 1.61
Price to Earnings (P/E)		 15.06 18.15 17.19 17.18 20.85 18.63 19.77 17.99 16.66 17.29 16.81
Dividend Yield		 4.82% 3.18% 3.18% 3.23% 2.77% 3.14% 2.99% 3.36% 3.71% 3.72% 3.49%
Earnings Yield		 6.64% 5.51% 5.82% 5.82% 4.80% 5.37% 5.06% 5.56% 6.00% 5.78% 5.95%
Enterprise Value to Invested Capital (EV/IC)		 1.16 1.28 1.26 1.27 1.39 1.28 1.29 1.23 1.13 1.16 1.19
Enterprise Value to Revenue (EV/Rev)		 2.22 2.68 2.92 2.95 3.38 3.28 3.59 3.35 3.10 3.33 3.19
Enterprise Value to EBITDA (EV/EBITDA)		 8.68 9.67 9.40 9.24 10.35 9.76 10.13 9.31 8.56 9.34 9.17
Enterprise Value to EBIT (EV/EBIT)		 15.45 17.15 16.47 16.30 18.68 17.98 18.86 17.55 16.32 17.45 16.56
Enterprise Value to NOPAT (EV/NOPAT)		 19.83 22.16 21.27 20.97 23.91 23.27 24.47 23.04 21.45 22.99 22.02
Enterprise Value to Operating Cash Flow (EV/OCF)		 13.93 13.96 12.74 12.37 12.84 12.91 11.54 11.52 11.70 13.58 14.34
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.35 1.39 1.34 1.32 1.41 1.47 1.53 1.53 1.33 1.53 1.47
Long-Term Debt to Equity		 1.06 1.05 0.99 1.00 1.27 1.26 1.20 1.20 1.07 1.05 1.00
Financial Leverage		 1.30 1.34 1.32 1.30 1.38 1.43 1.44 1.43 1.36 1.50 1.49
Leverage Ratio		 3.41 3.41 3.32 3.31 3.42 3.46 3.43 3.44 3.35 3.50 3.46
Compound Leverage Factor		 0.43 2.47 2.77 1.32 -0.73 2.57 2.76 1.16 -0.73 2.56 2.79
Debt to Total Capital		 57.36% 58.14% 57.20% 56.80% 58.48% 59.53% 60.54% 60.50% 57.04% 60.43% 59.43%
Short-Term Debt to Total Capital		 12.13% 14.28% 14.65% 13.81% 5.72% 8.74% 13.14% 13.07% 10.96% 19.06% 18.87%
Long-Term Debt to Total Capital		 45.23% 43.87% 42.56% 42.99% 52.76% 50.79% 47.40% 47.43% 46.08% 41.38% 40.56%
Preferred Equity to Total Capital		 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 42.62% 41.84% 42.78% 43.18% 41.50% 40.45% 39.45% 39.48% 42.95% 39.55% 40.55%
Debt to EBITDA		 4.29 4.40 4.26 4.13 4.35 4.53 4.75 4.59 4.35 4.88 4.61
Net Debt to EBITDA		 4.25 4.36 4.22 4.11 4.32 4.49 4.69 4.54 4.27 4.80 4.52
Long-Term Debt to EBITDA		 3.39 3.32 3.17 3.12 3.93 3.86 3.72 3.60 3.52 3.34 3.14
Debt to NOPAT		 9.80 10.08 9.64 9.37 10.06 10.80 11.48 11.36 10.91 12.00 11.06
Net Debt to NOPAT		 9.71 9.99 9.55 9.33 9.98 10.71 11.34 11.24 10.71 11.80 10.86
Long-Term Debt to NOPAT		 7.73 7.61 7.17 7.09 9.08 9.21 8.99 8.91 8.82 8.22 7.55
Altman Z-Score		 0.79 0.86 0.89 0.80 0.89 0.84 0.83 0.72 0.69 0.67 0.77
Noncontrolling Interest Sharing Ratio		 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.03%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.64 0.64 0.68 0.58 0.91 0.83 0.66 0.58 0.67 0.56 0.57
Quick Ratio		 0.55 0.56 0.60 0.49 0.76 0.72 0.57 0.48 0.58 0.50 0.49
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -84 -74 -41 -63 -81 -79 -119 -153 -164 -240 -167
Operating Cash Flow to CapEx		 45.53% 59.45% 131.68% 135.97% 45.47% 41.91% 159.82% 104.98% 28.57% 37.09% 154.63%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.37 0.34 0.31 0.31 0.30 0.29 0.27 0.28 0.27 0.27 0.29
Accounts Receivable Turnover		 4.66 3.57 3.16 3.89 3.83 3.23 3.08 3.75 3.66 3.03 3.38
Inventory Turnover		 33.65 27.01 25.80 24.18 23.18 20.01 18.47 18.41 18.73 19.68 20.92
Fixed Asset Turnover		 0.44 0.40 0.37 0.36 0.34 0.33 0.32 0.32 0.32 0.32 0.34
Accounts Payable Turnover		 12.17 6.43 8.43 9.33 9.27 6.12 7.04 7.34 7.35 5.59 7.73
Days Sales Outstanding (DSO)		 78.30 102.34 115.67 93.78 95.38 113.09 118.41 97.42 99.65 120.60 107.91
Days Inventory Outstanding (DIO)		 10.85 13.51 14.15 15.09 15.74 18.24 19.76 19.83 19.49 18.55 17.44
Days Payable Outstanding (DPO)		 30.00 56.74 43.32 39.14 39.39 59.61 51.85 49.76 49.66 65.28 47.20
Cash Conversion Cycle (CCC)		 59.15 59.12 86.50 69.74 71.74 71.71 86.32 67.49 69.47 73.87 78.16
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,126 1,169 1,194 1,181 1,211 1,269 1,351 1,349 1,383 1,535 1,559
Invested Capital Turnover		 0.55 0.50 0.45 0.44 0.43 0.41 0.38 0.39 0.39 0.38 0.40
Increase / (Decrease) in Invested Capital		 95 95 74 74 85 100 153 165 169 266 208
Enterprise Value (EV)		 1,305 1,494 1,507 1,498 1,681 1,625 1,747 1,655 1,558 1,783 1,855
Market Capitalization		 666 820 830 831 980 877 937 847 780 868 939
Book Value per Share		 $29.80 $30.38 $31.71 $31.46 $31.05 $31.64 $32.86 $32.77 $36.64 $34.02 $35.35
Tangible Book Value per Share		 $29.80 $30.38 $31.71 $31.46 $31.05 $31.64 $32.86 $32.68 $36.55 $33.78 $35.11
Total Capital		 1,125 1,169 1,194 1,178 1,210 1,267 1,354 1,349 1,390 1,541 1,568
Total Debt		 646 680 683 669 708 754 819 816 793 931 932
Total Long-Term Debt		 509 513 508 506 638 643 642 640 641 638 636
Net Debt		 640 673 676 666 701 748 809 808 778 916 915
Capital Expenditures (CapEx)		 36 48 20 37 57 56 33 40 55 58 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 44 60 81 46 46 65 68 44 47 92 100
Debt-free Net Working Capital (DFNWC)		 50 67 88 48 53 71 78 53 61 108 117
Net Working Capital (NWC)		 -87 -100 -87 -114 -17 -40 -100 -123 -91 -186 -179
Net Nonoperating Expense (NNE)		 9.80 5.94 5.65 6.58 4.06 5.45 6.84 7.32 5.20 6.96 7.95
Net Nonoperating Obligations (NNO)		 646 679 684 672 709 756 817 816 786 925 923
Total Depreciation and Amortization (D&A)		 17 17 18 18 19 21 22 22 22 23 23
Debt-free, Cash-free Net Working Capital to Revenue		 7.39% 10.81% 15.77% 8.98% 9.32% 13.04% 13.99% 8.99% 9.30% 17.22% 17.18%
Debt-free Net Working Capital to Revenue		 8.40% 11.97% 16.99% 9.53% 10.59% 14.31% 16.08% 10.71% 12.21% 20.13% 20.08%
Net Working Capital to Revenue		 -14.77% -17.99% -16.91% -22.50% -3.34% -8.06% -20.44% -24.99% -18.15% -34.65% -30.75%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.09 $0.97 $1.69 $0.27 $0.00 $0.97 $1.69 $0.25 ($0.02) $1.05 $1.85
Adjusted Weighted Average Basic Shares Outstanding		 16.10M 16.05M 16.10M 16.10M 16.10M 16.10M 16.15M 16.17M 16.98M 16.79M 17.87M
Adjusted Diluted Earnings per Share		 $0.09 $0.97 $1.69 $0.27 $0.00 $0.97 $1.69 $0.25 ($0.02) $1.05 $1.85
Adjusted Weighted Average Diluted Shares Outstanding		 16.10M 16.05M 16.10M 16.10M 16.10M 16.11M 16.16M 16.18M 16.98M 16.79M 17.88M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.10M 16.16M 16.17M 16.17M 16.19M 16.25M 16.25M 16.29M 17.91M 17.98M 17.99M
Normalized Net Operating Profit after Tax (NOPAT)		 5.60 21 33 11 4.06 21 34 11 4.90 26 41
Normalized NOPAT Margin		 5.39% 16.54% 18.38% 11.37% 4.37% 16.51% 20.10% 11.03% 4.85% 16.07% 18.97%
Pre Tax Income Margin		 0.96% 15.51% 20.48% 5.12% -1.40% 16.39% 21.66% 4.58% -1.58% 15.73% 20.79%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 58.37% 57.96% 54.87% 55.37% 57.87% 58.39% 59.07% 60.30% 61.75% 59.96% 55.99%
Augmented Payout Ratio		 58.37% 57.96% 54.87% 55.37% 57.87% 58.39% 59.07% 60.30% 61.75% 59.96% 55.99%

Financials Breakdown Chart

Key Financial Trends

Here are observed trends for Unitil Corp (NYSE: UTL) across the last four years, based on quarterly statements provided. The focus is on meaningful shifts in revenue, earnings, cash flow, and the balance sheet that could impact investors.

  • Operating cash flow from continuing activities rose to $21,400,000 in Q4 2025, up from $15,600,000 in Q3 2025, signaling ongoing positive cash generation.
  • Net cash from financing activities in Q4 2025 was $126,300,000, supported by a debt issuance of $138,200,000 (plus a small equity issuance), providing liquidity for investments and debt management.
  • Total equity rose to $597,000,000 in Q4 2025, up from $532,600,000 in Q3 2025, indicating a larger equity base.
  • Operating revenue in Q4 2025 was $161,500,000, rebounding to levels seen in 2022 and higher than the trough in 2023–2024.
  • Total assets increased from about $1.89B at the end of Q1 2025 to about $1.944B by Q3 2025, reflecting asset growth through the year.
  • Long-term debt hovered around the high $600 millions (approximately $638M in Q3 2025), indicating higher leverage but within a financing framework that supported cash flow and capital needs.
  • Weighted average shares outstanding (basic/diluted) remained in the high-teens, around 17.9 million, indicating modest quarterly dilution without dramatic changes.
  • Net income from continuing operations was negative in Q3 2025 at approximately $-0.3M, highlighting quarterly earnings volatility even as revenue grew.
  • Investing cash flows were notably negative in 2025 due to capital expenditures, for example PPE purchases of about $54.6M in Q3 2025 and $57.7M in Q4 2025, which weighed on free cash flow.
05/14/26 11:53 AM ETAI Generated. May Contain Errors.

Unitil Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Unitil's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 10 years, Unitil's net income changed from $26.30 million in 2015 to $50.20 million in 2025, a change of 90.9%. Find out what analysts predict for Unitil in the coming months.

Unitil's total operating income in 2025 was $101.20 million, based on the following breakdown:
  • Total Gross Profit: $221.20 million
  • Total Operating Expenses: $120 million

Over the last 10 years, Unitil's total revenue changed from $426.80 million in 2015 to $536 million in 2025, a change of 25.6%.

Unitil's total liabilities were at $1.52 billion at the end of 2025, a 18.9% increase from 2024, and a 101.7% increase since 2015.

In the past 10 years, Unitil's cash and equivalents has ranged from $5.20 million in 2019 to $15.60 million in 2025, and is currently $15.60 million as of their latest financial filing in 2025.

Over the last 10 years, Unitil's book value per share changed from 20.21 in 2015 to 34.02 in 2025, a change of 68.3%.


Related Companies

Financial statements for NYSE:UTL last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Elon’s ‘iPhone’ Could 10x Apple’s iPhone
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel